Key Takeaways
- Shares of Palantir declined approximately 4.8% to $127.88 on Wednesday, halting a seven-session rally that had delivered 25% gains.
- A Financial Times article highlighted potential risks from Democratic lawmakers who may scrutinize Palantir’s federal work if they reclaim House control.
- Palantir secured approximately $2.2 billion from federal contracts in the year following Trump’s inauguration, representing a 65% annual increase.
- Technical indicators show PLTR remains beneath its 100-day and 200-day moving averages, with a Death Cross pattern active since February.
- Wall Street consensus leans Buy with an average target of $174.10; the company’s next earnings announcement is projected for August 3.
Palantir Technologies (PLTR) stock experienced a significant downturn Wednesday, bringing an end to a week-long rally. Shares retreated approximately 4.8% to settle at $127.88, positioning the stock among the S&P 500’s biggest decliners for the session.
Palantir Technologies Inc., PLTR
The decline followed a Financial Times article that highlighted internal apprehensions at the company and raised the prospect of Democratic lawmakers employing subpoena authority to examine Palantir’s government relationships should they secure House majority control.
DA Davidson’s Gil Luria told Barron’s the stock movement seems directly connected to the published report. However, Luria challenged the political risk concerns, emphasizing that Palantir has maintained Defense Department relationships through five different administrations spanning both political parties.
“Each successive administration has expanded its reliance on Palantir’s capabilities beyond what came before,” Luria noted.
The context is significant. PLTR had just finished Tuesday’s session precisely at its 50-day moving average, hovering near $134. Wednesday’s downward reversal indicates the stock encountered resistance at that technical threshold before retreating.
Palantir declined to provide a statement when contacted.
Congressional Attention and Federal Contracts
Political controversy surrounding Palantir isn’t unprecedented, but the FT article brought it into sharper focus. The company has faced pushback regarding its involvement with immigration enforcement agencies, defense departments, and Israel’s military operations in Gaza.
What intensifies the current scrutiny is the substantial revenue involved. Palantir recorded approximately $2.2 billion from federal contracts during the 12 months after Trump resumed office — representing a 65% surge compared to the previous year. Meanwhile, commercial revenue more than doubled during the same timeframe.
Any interruption to these government agreements would inflict genuine damage to operations, extending beyond mere perception concerns.
Notable investor Michael Burry has established a short position on PLTR, contending that Anthropic is encroaching on Palantir’s artificial intelligence domain. CEO Alex Karp has rejected this assessment, maintaining that large-scale AI models generate challenges that Palantir specifically addresses for clients.
Technical Analysis of PLTR
The overall technical landscape remains challenging. PLTR currently trades 18.6% beneath its 200-day moving average of $157.31 and 7.9% under its 100-day moving average of $139.05. A Death Cross formation — occurring when the 50-day crosses below the 200-day — emerged in February and persists.
Palantir stock has declined 29% year-to-date in 2026 and remains 39% off its record closing peak of $207.18 reached on November 3, 2025.
The recent rally had provided temporary optimism. Following a bottom of $107.27 on June 25, PLTR surged 25% across seven trading days. That momentum stemmed partly from an announced collaboration with Nvidia to develop specialized AI solutions for federal agencies, complemented by DA Davidson’s upgrade to Buy with a $175 price target.
Wednesday’s selloff halted that positive momentum.
Investors will next focus on the company’s quarterly results, anticipated for August 3. Wall Street analysts forecast earnings per share of 33 cents, up from 16 cents last year, alongside revenue of $1.81 billion versus $1.00 billion in the comparable period.
Analyst consensus stands at Buy with an average price objective of $174.10.
